Agios Pharmaceuticals, Inc. (AGIO)
27.68
-0.51
(-1.81%)
USD |
NASDAQ |
Mar 05, 16:00
26.99
-0.69
(-2.49%)
Pre-Market: 08:39
Agios Pharmaceuticals Cash from Investing (TTM) : 377.18M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Gilead Sciences, Inc. | -4.793B |
| CorMedix, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 436.33M |
| Enanta Pharmaceuticals, Inc. | -75.85M |
| Karyopharm Therapeutics, Inc. | 43.38M |